NxStage Medical, Inc. (NXTM) Tops Q4 EPS by 5c; Issues Light Outlook
Tweet Send to a Friend
NxStage Medical, Inc. (NASDAQ: NXTM) reported Q4 loss of $0.04 per share, versus the analyst estimate of ($0.05). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
